Hyperalphalipoproteinemia: Characterization of a cardioprotective profile associating increased high-density lipoprotein2 levels and decreased hepatic lipase activity

Metabolism: Clinical and Experimental

Volumn 47, Issue 8, 1998, Pages 965-973

  Sich, Didier ^a   Saïdi, Youssef ^b   Giral, Philippe ^b   Lagrost, Laurent ^b   Egloff, Monique ^b   Auer, Claude ^b   Gautier, Valérie ^b   Turpin, Gérard ^b   Beucler, Isabel ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; LIVER TRIACYLGLYCEROL LIPASE; PHOSPHOLIPID TRANSFER PROTEIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEART PROTECTION; HUMAN; HYPERLIPOPROTEINEMIA; LIPID ANALYSIS; LIPOPROTEIN METABOLISM; MALE; PRIORITY JOURNAL;

EID: 0031904053     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90352-3     Document Type: Article

References (62)

1. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature 362:801-809, 1993
2. Wallace RB, Anderson RA: Blood lipids, lipid-related measures and the risk of atherosclerotic cardiovascular disease. Epidemiol Rev 9:95-119, 1987
3. Gordon DJ, Rifkind BM: High-density lipoprotein: The clinical implications of recent studies. N Engl J Med 321:1311-1316, 1989
4. Barter PJ, Rye KA: High density lipoproteins and coronary heart disease. Atherosclerosis 121:1-12, 1996
5. Campos H, Genest JJ, Blijlevens E, et al: Low density lipoprotein particle size and coronary artery disease. Arteriose Thromb 12:187-195, 1992
6. Austin MA, Breslow JL, Hennekens CH, et al: Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260:1917-1921, 1988
7. Miller NE: Association of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J 113:589-597, 1987
8. Robinson D, Ferns GAA, Bevan EA, et al: High density lipoprotein subfractions and coronary risk factors in normal men. Arteriosclerosis 7:341-346, 1987
9. Johansson J, Carlson LA, Landou C, et al: High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients. Arteriose Thromb 11:174-182, 1991
10. Blanche PJ, Gong EL, Forte TM, et al: Characterization of human high-density lipoproteins by gradient gel electrophoresis. Biochim Biophys Acta 665:408-419, 1981
11. Cheung MC, Albers JJ: Characterization of lipoprotein particles isolated by immunoaffinity chromatography. J Biol Chem 259:12201-12209, 1984
12. Duverger N, Rader D, Duchateau P, et al: Biochemical characterization of the three major subclasses of lipoprotein A-I preparatively isolated from human plasma. Biochemistry 32:12372-12379, 1993
13. Duverger N, Rader D, Brewer BH Jr: Distribution of subclasses of HDL containing apoA-I without apoA-II (LpA-I) in normolipidemic men and women. Arteriose Thromb 14:1594-1599, 1994
14. Cheung MC, Brown GB, Wolf AC, et al: Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease. J Lipid Res 32:383-394, 1991
15. Tall A: Plasma lipid transfer proteins. Annu Rev Biochem 64:235-257, 1995
16. Lagrost L, Gambert P, Dangremont V, et al: Role of cholesteryl ester transfer protein (CETP) in the HDL conversion process as evidenced by using anti-CETP monoclonal antibodies. J Lipid Res 31:1569-1575, 1990
17. Tu AY, Nishida HI, Nishida T: High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J Biol Chem 268:23098-23105, 1993
18. Jauhiainen M, Metso J, Pahlman R, et al: Human phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem 268:4032-4036, 1993
19. Taskinen M-R, Glueck CJ, Kashyap ML, et al: Postheparin plasma lipoprotein and hepatic lipases: Relationships to high density lipoprotein cholesterol and apolipoprotein C-II in familial hyperalphalipoproteinemic and normal subjects. Atherosclerosis 37:247-256, 1980
20. Kuusi T, Ehnholm C, Viikari J, et al: Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia. J Lipid Res 30:1117-1126, 1989
21. Yamashita S, Hui D, Wetterau JR, et al: Characterization of plasma lipoproteins in patients heterozygous for human plasma cholesteryl ester transfer protein (CETP) deficiency: Plasma CETP regulates high-density lipoprotein concentration and composition. Metabolism 40:756-763, 1991
22. Inazu A, Brown ML, Hesler CB, et al: Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med 323:1234-1238, 1990
23. Hirano K, Yamashita S, Kuga Y, et al: Atherosclerosis disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase. Arterioscler Thromb Vasc Biol 15:1849-1856, 1995
24. The Expert Panel 1993: Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II) NHLBI. JAMA 269:3015-3023, 1993
25. Schaefer EJ, Lamon-Fava S, Ordovas JM, et al: Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study. J Lipid Res 35:871-882, 1994
26. Bruckert E, Giral P, Salloum J, et al: Carotid stenosis is a powerful predictor of a positive exercise electrocardiogram in a large hyperlipidemic population. Atherosclerosis 92:105-114, 1992
27. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 18:499-502, 1972
28. Parra HJ, Mezdour H, Ghalim N, et al: Differential electroimmunoassay of human LpA-I lipoprotein particles on ready-to-use plates. Clin Chem 36:1431-1435, 1990
29. Chapman MJ, Goldstein S, Lagrange D, et al: A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum. J Lipid Res 22:339-358, 1981
30. Lowry OH, Rosebrough NJ, Farr AL, et al: Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275, 1951
31. Lagrost L, Gandjini H, Athias A, et al: Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profile in normolipidemic subjects. Arteriosc Thromb 13:815-825, 1993
32. Albers JJ, Tbllefson JH, Chen C-H, et al: Isolation and characterization of human plasma lipid transfer proteins. Arteriosclerosis 4:49-58, 1984
33. Mann CJ, Yen FT, Grant AM, et al: Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest 88:2059-2066, 1991
34. Lagrost L, Athias A, Gambert P, et al: Comparative study of phospholipid transfer activities mediated by cholesteryl ester transfer protein and phospholipid transfer protein. J Lipid Res 35:825-835, 1994
35. 14C] phosphatidylcholine between liposomes and human plasma high density lipoprotein: Partial purification of a transfer-stimulating plasma factor using a rapid transfer assay. Biochim Biophys Acta 712:444-452, 1982
36. Nilsson-Ehle P, Ekman R: Rapid simple and specific assays for lipoprotein lipase and hepatic lipase. Artery 3:194-209, 1977
37. Belfrage P, Vaughan M: Simple liquid-liquid partition system for isolation of labeled oleic acid from mixtures with glycerides. J Lipid Res 10:341-345, 1969
38. Scanu AM, Kruski AW: The chemistry of serum lipoproteins, in Masoro E (ed): International Encyclopedia of Pharmacology and Therapeutics. New York, NY, Plenum, 1985, pp 21-38
39. Wofford JL, Kahl FR, Howard GR, et al: Relation of extent of extracranial carotid artery atherosclerosis as measured by B-mode ultrasound to the extent of coronary atherosclerosis. Arteriosc Thromb 11:1786-1794, 1991
40. Salonen JT, Salonen R: Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arteriosc Thromb 11:1245-1249, 1991
41. Schaefer EJ, Lamon-Fava S, Cohn SD, et al: Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study. J Lipid Res 35:779-792, 1994
42. Wilson HM, Patel JC, Skinner ER: The distribution of high density lipoprotein subfractions in coronary survivors. Biochem Soc Trans 18:1175-1176, 1990
43. Tornvall P, Karpe F, Proudler A, et al: High-density lipoprotein: Relations to metabolic parameters and severity of coronary artery disease. Metabolism 45:1375-1382, 1996
44. Cambien F, Parra HJ, Arveiler D, et al: Lipoprotein particles in patients with myocardial infarction and controls. Circulation 348:1380, 1990
45. Parra HJ, Arveiler D, Evans AE, et al: A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease: The ECTIM study. Arteriosc Thromb 12:701-707, 1992
46. Barbaras R, Puchois P, Fruchart JC, et al: Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII. Biochem Biophys Res Commun 142:63-69, 1987
47. Decossin C, Castro G, Derudas B, et al: Subclasses of LpA-I in coronary artery disease: Distribution and cholesterol efflux ability. Eur J Clin Invest 27:299-307, 1997
48. Bagdade JD, Ritter MC, Subbaiah PV: Accelerated cholesteryl ester transfer in plasma of patients with hypercholesterolemia. J Clin Invest 21:161-167, 1991
49. McPherson R, Mann CJ, Tall AR, et al: Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia: Relation to cholesteryl ester transfer protein activity and other lipoprotein variables. Arteriose Thromb 11:797-804, 1991
50. McPherson R, Martin L, Zhang ZJ, et al: Effects of dietary cholesterol on plasma cholesteryl ester transfer protein (CETP) concentration in man. Arteriosclerosis 10:818a, 1990 (abstr)
51. Jiang XC, Agellon LB, Walsh A, et al: Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice. J Clin Invest 90:1290-1295, 1992
52. Hirano K, Yamashita S, Nakajima N, et al: Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan: Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity. Arterioscler Thromb Vasc Biol 17:1053-1059, 1997
53. Zhong S, Sharp DS, Grove JS, et al: Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest 97:2917-2923, 1996
54. 1HDL. Biochim Biophys Acta 1301:255-262, 1996
55. Lagrost L, Athias A, Herbeth B, et al: Opposite effects of cholesteryl ester transfer protein and phospholipid transfer protein on the size distribution of plasma high density lipoproteins. J Biol Chem 271:19058-19065, 1996
56. Taskinen MR, Nikkilä EA: High density lipoprotein subfractions in relation to lipoprotein lipase activity of tissue in man: Evidence for reciprocal regulation of HDL2 and HDL3 levels by lipoprotein lipase. Clin Chim Acta 112:325-332, 1981
57. Kuusi T, Nikkilä A, Tikkanen MJ, et al: Role of hepatic lipase in lipoprotein metabolism, in Schettler G, Gotto AM Jr, Middelhoff G, et al (eds): Atherosclerosis VI. Berlin, Germany, Springer Verlag, 1982, pp 628-632
58. 2 subfractions with hepatic lipase. J Lipid Res 33:1269-1279, 1992
59. Hegele RA, Little JA, Vezina C, et al: Hepatic lipase deficiency. Clinical, biochemical and molecular genetic characteristics. Arteriosc Thromb 13:720-728, 1993
60. Cohen JC, Wang Z, Grundy SM, et al: Variation at the hepatic lipase and apolipoprotein AI/CII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J Clin Invest 94:2377-2384, 1994
61. Pagani F, Sidoli A, Giudici GA, et al: Human apolipoprotein A-I gene promoter polymorphism: Association with hyperalphalipoproteinemia. J Lipid Res 31:1371-1377, 1990
62. Rigotti A, Trigatti B, Babitt J, et al: Scavenger receptor BI - A cell surface receptor for high density lipoprotein. Curr Opin Lipidol 8:181-188, 1997